Mallinckrodt
-
Malvern’s Endo Enters Into Agreement to Merge with Mallinckrodt in $6 Billion Deal
Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical company at $6.7 billion, writes John George…
Founding Partners
Advertisement
Affiliate Partners
